Latest News

NOX to support expanded LuPIN study
Nyrada-Key progress with cholesterol-lowering drug candidate
VEYONDA - Registered Trade Mark for NOX66
Interim NOX66 Radiotherapy Clinical Data
Release of DARRT-1 Preliminary Safety Data
Pre-Clinical data confirms Radio-Enhancing potential
Noxopharm Corporate Presentation for Public Briefing
End-of-Study Clinical Data shows benefit of NOX66
NOX to present at American Society of Clinical Oncology
Noxopharm 2018 Mid-Year Investor Briefings